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Abstract Syk deficiency significantly enhanced ceramide-in-
duced apoptosis. Ectopic expression of wild-type or kinase-
inactive Syk rendered Syk-negative cells resistant to ceramide-
induced apoptosis. Furthermore, ceramide could not activate
Syk, indicating that Syk protected DT40 cells from ceramide-
induced apoptosis, via a mechanism independent of its activity. In
addition, a deficiency in Lyn also resulted in the cells becoming
susceptible to ceramide-induced apoptosis. However, no differ-
ence of Ara-C-induced apoptosis between wild-type and mutant
cells was observed. c-Jun N-terminal kinases appeared not to be
important in mediating the enhanced apoptosis, as they were still
activated in mutant cells following ceramide treatment.
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1. Introduction
Apoptosis is a unique morphological pattern of cell death
characterized by chromatin condensation and membrane bleb-
bing. The most prominent event, also a biochemical marker in
the early stages, of apoptosis is the internucleosomal DNA
cleavage by unde¢ned endonuclease activities. It is generally
believed that apoptosis plays important roles in developmen-
tal processes, maintenance of homeostasis, and elimination of
cells that have su¡ered serious damage [1,2]. The mechanisms
by which cells undergo apoptosis in response to various
changes of environments are gradually becoming understood
with a growing body of evidence demonstrating that protein
kinases have important roles to play in cell apoptosis. Several
non-receptor protein tyrosine kinases (PTKs), including Abl
[3], Jak2 [4], Btk [5], Lyn [6] and Syk [7], have been shown to
be either positive or negative regulators of apoptosis in re-
sponse to cellular stresses. Furthermore, Syk is also involved
in the regulation of receptor engagement-induced apoptosis in
immature B cells [8] and of growth factor withdrawal-trig-
gered apoptosis in eosinophils [9]. In addition to PTKs, c-
Jun N-terminal kinases (JNKs) are strongly activated by stim-
uli other than growth factors, including signals as diverse as
UV irradiation [10], osmotic shock [11,12], protein synthesis
inhibitors [13], and tumor necrosis factor K stimulation [14].
Various cellular stresses as the best activators of JNK indicate
that JNK activation may be critical for regulating cell surviv-
al. In fact, JNK activation is required for cell apoptotic re-
sponses triggered by growth factor withdrawal [15] or envi-
ronmental stresses [16]. JNK activation, however, seems also
likely to be involved in promoting cell survival. Blocking JNK
activation correlates well with the inhibition of IgM-induced
apoptosis in immature B cells and of CD95- or CD3-induced
apoptosis in thymocytes [17,18]. Moreover, recent studies
have revealed that PTKs including Abl [19,20], Pyk2 [21]
and Syk [22] are upstream mediators of JNK activation in
response to certain types of cellular stresses, suggesting a pos-
sibility that PTKs and JNKs may work in concert in the
regulation of some cell responses in certain cell systems.
Ceramide, a product of sphingomyelin hydrolysis, has been
implicated as a second messenger in apoptotic response trig-
gered by various cellular stresses, such as heat shock, ultra-
violet light, oxidative stress, ionizing radiation, tumor necrosis
factor K, and Fas ligand [16,22^26]. Substantial lines of evi-
dence are derived from studies showing that rapid ceramide
generation by stresses correlates well with the subsequent
apoptotic response [16,27]. Recently, a direct demonstration
of ceramide as a primary mediator of the apoptotic response
has been observed by investigating radiation-induced apopto-
sis in lymphoblasts from Niemann-Pick patients lacking ex-
pression of acid sphingomyelinase and from acid sphingomye-
linase knockout mice [28]. A few e¡ectors for ceramide have
been identi¢ed, including JNKs [16], ceramide-activated pro-
tein kinase [29] and c-Raf [30]; however, the mechanisms by
which ceramide regulates apoptotic response are elusive.
Considering the results showing that Syk plays critical roles
in the regulation of apoptosis [7^9], we investigated the in-
volvement of Syk in ceramide-induced apoptosis utilizing Syk-
negative mutants. We report here that Syk protected DT40
cells from ceramide-induced apoptosis, via a mechanism in-
dependent of its activity and JNK activation.
2. Materials and methods
2.1. Materials and chemicals
Generation of Syk3, Lyn3, Syk3/Syk cells was done as described
previously [31]. RPMI 1640 was purchased from ICN Biomedicals.
Fetal bovine serum was from Gibco. Protein A was from Calbiochem.
Anti-phosphotyrosine antibody (4G10) was from Upstate Biotechnol-
ogy. Mouse anti-human JNK1 monoclonal antibody was purchased
from Pharmingen (San Diego, CA, USA). Enhanced chemilumines-
cence (ECL) reagents were from Amersham. Glutathione Sepharose
4B was from Pharmacia. C2-ceramide was from Sigma. GST expres-
sion vector containing the N-terminal fragment (amino acids 1^79) of
c-Jun was a gift from Dr. Hibi (Osaka University, Japan).
2.2. Cell culture and harvesting
DT40 cells were maintained in RPMI 1640 medium, supplemented
with 10% (v/v) fetal bovine serum, 100 U/ml penicillin and 100 Wg/ml
streptomycin in a humidi¢ed 95% air/5% CO2 atmosphere. The parent
culture was maintained in continuous logarithmic growth at (5^
10)U105 cells/ml. For experiment use, cells were collected by centri-
fugation, washed once with NaCl/Pi bu¡er (136.8 mM NaCl, 2.68 mM
KCl, 8.04 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4) and then
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suspended (1U107 cells/ml) in Hanks’ balanced salt solution (HBSS:
136.7 mM NaCl, 5.4 mM KCl, 0.81 mM MgSO4, 1.3 mM CaCl2, 0.33
mM Na2HPO4, 0.44 mM KH2PO4, 5.6 mM dextrose, 4.2 mM
NaHCO3, pH 7.4). Cells were stimulated at 37‡C with gentle stirring.
2.3. Preparation of GST fusion protein and of cell extracts
Puri¢cation of GST-c-Jun fusion protein and cell lysate preparation
were carried out as described previously [22].
2.4. Immunoblot analysis and JNK assay
Western blot and kinase assay for JNK were performed following
the described procedures [22].
2.5. DNA fragmentation analysis
Cells (5U105/ml) were treated with ceramide in RPMI 1640 me-
dium for the indicated times. 5U106 cells were lysed in 0.5 ml of lysis
bu¡er (10 mM Tris-HCl, pH 7.5, 10 mM EDTA, 200 mM NaCl, 0.4%
Triton X-100 and 0.1 mg/ml proteinase K) for 20 min at room tem-
perature followed by a 30-min incubation with 0.1 mg/ml RNase A at
50‡C. The DNA fragmentation was analyzed on a 2% agarose gel in
the presence of 0.5 Wg/ml ethidium bromide.
3. Results
3.1. Inhibition of ceramide-induced apoptosis by Syk
The capacity of ceramide to induce apoptosis in DT40 cells
was ¢rst examined, as assessed by DNA fragmentation, a
typical biochemical marker of apoptosis. After exposure of
DT40 cells to various doses of ceramide for 16 h, DNA was
extracted and run in a 2% agarose gel containing ethidium
bromide. Ceramide less than 10 WM was unable to elicit an
apoptotic response (Fig. 1). When the ceramide concentration
was over 25 WM, in particular at a dose of 50 WM, cells sub-
jected to ceramide treatment underwent apparent apoptosis.
In following experiments, 50 WM ceramide was therefore used
for the studies of apoptosis. To explore whether Syk played a
role in regulating ceramide-induced apoptosis, wild-type and
Syk-negative DT40 cells were treated with ceramide. As
shown in Fig. 1, the nucleosomal DNA ladders appeared
16 h after ceramide treatment in wild-type cells. In Syk-neg-
ative cells, however, apparent DNA fragmentation occurred
at 8 h, and the magnitude of fragmented DNA was continu-
ously increased, indicating the progression of massive frag-
mentation of chromosomal DNA. To demonstrate more def-
initely a role of Syk in ceramide-induced apoptosis in DT40
cells, we introduced a porcine syk cDNA into Syk-negative
cells. Expression of porcine Syk in Syk-negative cells rendered
cells resistant to ceramide-induced apoptosis, providing clear
evidence that Syk appeared to inhibit ceramide-induced apop-
tosis.
3.2. Syk activity was not critical for the protection of cells from
ceramide-induced apoptosis
To evaluate the importance of Syk activity in ceramide-
induced apoptosis, we transfected kinase-inactive porcine syk
cDNA into Syk-negative cells. The lack of Syk activity was
demonstrated by an in vitro kinase assay, which showed there
was no detectable autophosphorylation, which is seen under
normal conditions (Fig. 2A, top). Expression levels of wild-
type and kinase-inactive porcine Syk were comparable, as
revealed by immunoblotting (Fig. 2A, bottom). As in the
case of Syk-negative cells expressing wild-type Syk, ectopic
expression of kinase-inactive Syk in Syk-negative cells con-
verted the cells resistant to ceramide (Fig. 2B). Consistent
with this was the observation that ceramide could not activate
Syk in DT40 cells under our experimental condition (Fig. 2C).
Together these ¢ndings indicate that Syk activity was not
required for its anti-apoptotic e¡ect observed.
3.3. Lyn was also involved in ceramide-induced apoptosis
Lyn, another predominantly expressed src-family PTK in
B-lineage cells [6,31], has been indicated to be an important
regulator of apoptosis [6,9] and of ligand-dependent Syk acti-
vation in hematopoietic cells [9,32]. To investigate the specif-
icity or the functional redundancy of PTKs in mediating cer-
amide-induced apoptosis in DT40 cells, the roles of Lyn in
cell apoptosis were examined, utilizing Lyn-negative cells es-
tablished by having this gene knocked out [31]. Under the
same experimental conditions as applied to Syk-negative cells,
a de¢ciency in Lyn also rendered the cells susceptible to cer-
amide-induced apoptosis, when compared with wild-type cells
(Fig. 3A), indicating that like Syk, Lyn has a role in the
protection of cells from ceramide-induced apoptosis. To
make sure that the observation was not due to clone altera-
tion, we examined the e¡ect of Syk and Lyn on apoptosis
induced by the anti-cancer drug Ara-C in a clinical concen-
tration. Treatment of DT40 cells with 10 WM Ara-C induced
apparent cell apoptosis as revealed by DNA laddering (Fig.
3B). A de¢ciency in either Syk or Lyn did not alter Ara-C-
induced apoptosis (Fig. 3B). Therefore, Syk and Lyn ap-
peared to be speci¢c inhibitors of ceramide-induced apoptosis
in DT40 cells.
3.4. Di¡erential regulation of ceramide-induced JNK activation
by Syk and Lyn
To address the responses of JNKs to ceramide in DT40
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Fig. 1. Inhibition of ceramide-induced apoptosis by Syk in DT40
cells. A: Dose dependence. Wild-type and Syk3 DT40 cells were
treated with the indicated concentrations of ceramide for 16 h. Ex-
tracted DNA was run in 2% agarose gel to detect DNA laddering.
B: Inhibition of ceramide-induced apoptosis by Syk. Wild-type,
Syk3 and Syk3/Syk cells were exposed to 50 WM ceramide for the
indicated time periods. Extracted DNA was run in 2% agarose gel
to detect DNA laddering.
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cells, the N-terminal domain (amino acids 1^79) of c-Jun
fused to GST was used as a probe to monitor JNK activity
before and after stimulation. Ceramide treatment activated
JNK in a time- and dose-dependent manner (Fig. 4A). Expo-
sure of cells to 100 WM ceramide stimulated a 10-fold increase
in JNK activity. JNK activity reached a peak at 15 min in-
cubation and decreased thereafter.
Abl, Pyk2 and Syk have recently been shown to positively
regulate the activation of JNKs in response to certain types of
cellular stress [19^22]. Further, JNK activation has been dem-
onstrated to correlate with apoptosis induced by cellular stress
[16]. These observations led us to analyze whether Syk or Lyn
regulated ceramide-induced apoptosis in DT40 cells via the
JNK pathway. As shown in Fig. 4B, in Syk-negative cells,
JNK was activated to a similar extent as observed in wild-
type cells, though somewhat di¡erent in kinetics. In Lyn-neg-
ative cells, JNK was still responsive to ceramide treatment.
However, the magnitude of JNK activation was two-fold re-
duced when compared to that observed in wild-type cells (Fig.
4C). Immunoblot analysis with an anti-JNK antibody showed
that the same amount of JNK in each sample was immuno-
precipitated (Fig. 4). A de¢ciency in either Syk or Lyn, there-
fore, did not abolish ceramide-induced JNK activation.
4. Discussion
An increase in intracellular ceramide both in vivo and in
vitro results in cell apoptosis [16,27,28]. Several e¡ectors of
ceramide, such as JNK [16], ceramide-activated protein kinase
[29] and c-Raf [30], have been identi¢ed, but how the death
signals elicited by ceramide are relayed to the nuclei is poorly
de¢ned. In this study, taking advantage of tyrosine kinase-
de¢cient mutants, we provide genetic evidence to show that
a de¢ciency in Syk or Lyn speeds up cell apoptosis in response
to ceramide treatment. The importance of Syk for ceramide-
induced apoptosis is further highlighted by showing that over-
expression of porcine Syk in Syk-negative cells makes cells
resistant to ceramide treatment. These results suggest a critical
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Fig. 2. Syk activity was not required for protecting cells from ceramide-induced apoptosis. A: Kinase activity and protein expression of porcine
wild-type and kinase-inactive Syk in Syk3 cells. Lysates from Syk3, Syk3/Syk, and Syk3/Syk(K3) cells were immunoprecipitated with anti-Syk
antibody and divided into two portions. One was used for the Syk immunocomplex kinase assay (top), the other for immunoblot analysis using
an anti-Syk antibody (bottom). B: DNA fragmentation assay. Extracted DNA was analyzed on a 2% agarose gel, containing ethidium bro-
mide, to detect DNA laddering. C: Ceramide did not activate Syk. Anti-phosphotyrosine immunoblot (top) and anti-Syk immunoblot (bottom)
of anti-Syk immunoprecipitates from DT40 cells after ceramide treatment. IP: immunoprecipitation; IB: immunoblot. The positions of molecu-
lar mass marker are shown on the left (kDa). An arrow represents the position of Syk.
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role for Syk in the regulation of ceramide-induced apoptosis.
We therefore asked whether ceramide treatment leads to Syk
activation. Unexpectedly, exposure of cells to ceramide up to
100 WM for 30 min failed to trigger a detectable increase in the
tyrosine phosphorylation of Syk, implying that Syk activity is
not important for its anti-apoptotic e¡ect against ceramide.
This notion is supported by evidence showing that expression
of kinase-inactive Syk in Syk-negative cells also renders cells
resistant to ceramide treatment. These results are di¡erent
from the observation showing that Syk activity is partly re-
quired for the protection of DT40 cells from osmotic stress-
induced apoptosis [7]. Treatment of cells with various stress
stimuli usually increases intracellular ceramide; however, the
involvement of ceramide in stress-induced apoptosis is com-
plex and still elusive. Ceramide production is not always re-
quired for stress-induced apoptosis [33^35] and is not always
able to trigger apoptosis [36]. Together with the observation
that osmotic stress, but not ceramide treatment, activates Syk,
it is reasonable that Syk activity has a marginal e¡ect on
ceramide-induced apoptosis. While the mechanism by which
Syk inhibits ceramide-induced apoptosis is not clear at
present, one may assume that Syk may function as an adaptor
to mediate the ceramide e¡ect. In this respect, SH2 domains
from a number of signaling molecules, including Src and Abl,
have been demonstrated to prohibit apoptosis, depending on
the speci¢c interaction with endogenous tyrosine-phosphoryl-
ated ligands [37], while apoptosis was not a¡ected by the
treatment with tyrosine kinase inhibitors such as herbimycin
A and genistein [37,38]. Evans et al. further identi¢ed the
adaptor protein Crk as an important regulator of apoptosis
through its SH2 and SH3 domains [39].
JNK is one of the ceramide e¡ectors and activation of JNK
pathway results in the inhibition of apoptosis induced by cer-
tain agonists [17,18,40]. The e¡ects of Syk and Lyn on JNK
activation by ceramide have been investigated. In DT40 cells,
a de¢ciency in Lyn partly inhibits ceramide-induced JNK ac-
tivation, whereas ceramide-triggered JNK activation remains
intact in Syk-negative cells. Accordingly, JNK activation ap-
pears not to be important in mediating the enhanced cell
apoptosis in Syk- or Lyn-negative cells following ceramide
treatment, although we cannot completely deny the involve-
ment of JNK in the enhancement of ceramide-induced apop-
tosis. One should be cautious in drawing conclusions regard-
ing JNK function in cell apoptosis, as this issue is quite
complex. JNK activation has also been reported to either
lead to apoptosis [15,16,41] or have nothing to do with apop-
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Fig. 3. Indispensability of Lyn for ceramide-induced apoptosis in
DT40 cells. A: Enhanced cell apoptosis in Lyn3 DT40 cells. Wild-
type and Lyn3 DT40 cells (5U105/ml) were exposed to 50 WM cer-
amide, and cells were collected at indicated time points. Cellular
DNA was extracted and analyzed on 2% agarose gel to detect
DNA laddering. B: Dispensability of Syk and Lyn for Ara-C-in-
duced apoptosis. Wild-type, Syk3 and Lyn3 DT40 cells (5U105/ml)
were exposed to 10 WM Ara-C, and cells were collected at indicated
time points. Cellular DNA was extracted and analyzed on 2% agar-
ose gel to detect DNA laddering.
Fig. 4. Di¡erential regulation of ceramide-induced JNK activation
by Syk and Lyn. A: Activation of JNK by ceramide in a time- and
dose-dependent manner. DT40 cells were stimulated with various
doses of ceramide for 15 min or with 50 WM ceramide for the
indicated time periods. B: Dispensability of Syk for JNK activation.
Wild-type and Syk3 DT40 cells were stimulated with 100 WM
ceramide for the indicated time periods. C: Partial requirement of
Lyn for ceramide-induced JNK activation. Wild-type and Lyn3
DT40 cells were stimulated with 100 WM ceramide for the indicated-
time periods. The JNK assay was performed as described in Sec-
tion 2.
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tosis [35] in response to various agonists. The real functions of
JNK in ceramide-induced apoptosis cannot be addressed until
JNK-null DT40 cells are available.
In conclusion, Syk is a speci¢c inhibitor of ceramide-in-
duced apoptosis in DT40 cells, as demonstrated by the com-
bined results showing that a de¢ciency in Syk enhances ceram-
ide-induced apoptosis, which is restored following ectopic
expression of Syk in Syk-negative cells, and that a de¢ciency
in Syk does not a¡ect Ara-C-induced apoptosis.
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